- Exchange: EN Brussels
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
ThromboGenics NV+ Add to Watchlist
THR:BB6.3940 EUR 0.1560 2.38%
As of 11:35:00 ET on 12/19/2014.
Company Profile for ThromboGenics NV (THR)
ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.
Key Executives for ThromboGenics NV (THR)
|Gustaaf Van Reet "Staf"Chairman||Patrik De HaesCEO/Executive Director|
|Luc PhilipsInterim CFO||Koen KasChief Scientific Officer|
|Laurence RaemdonckHead:Human Resources||Andy De DeeneHead:Product Dev|
|David PearsonHead:Corporate Dev||Aniz GirachHead:Clinical Dev|
|Paul De NijsHead:Market Access|